Interval Debulking Surgery in Patients with Federation of Gynecology and Obstetrics (FIGO) Stage IIIC and IV Ovarian Cancer
Author(s) -
Mig-Denise Keyver-Paik,
Oliver Zivanovic,
Christian Rudlowski,
Tobias Höller,
Matthias Wolfgarten,
Kirsten Kübler,
Lars Schröder,
Michael R. Mallmann,
Martin Pölcher,
Walther Kuhn
Publication year - 2013
Publication title -
oncology research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.553
H-Index - 48
eISSN - 2296-5262
pISSN - 2296-5270
DOI - 10.1159/000351256
Subject(s) - medicine , debulking , perioperative , stage (stratigraphy) , ovarian cancer , surgery , gynecology , chemotherapy , obstetrics and gynaecology , gastroenterology , cancer , pregnancy , paleontology , biology , genetics
The feasibility of neoadjuvant chemotherapy (NAC) and the outcome in patients with Federation of Gynecology and Obstetrics (FIGO) IIIC and IV ovarian cancer were assessed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom